461 related articles for article (PubMed ID: 17922457)
1. [Development of extracorporeal blood purification methods: Molecular Adsorbent Recirculating System (MARS) for hepatic and renal function replacement].
Marangoni R
G Ital Nefrol; 2007; 24 Suppl 38():92-6. PubMed ID: 17922457
[TBL] [Abstract][Full Text] [Related]
2. [Molecular Adsorbent Recirculating System in liver function replacement therapy].
Marangoni R
G Ital Nefrol; 2005; 22 Suppl 31():S156-60. PubMed ID: 15786394
[TBL] [Abstract][Full Text] [Related]
3. Liver support technology--an update.
Rozga J
Xenotransplantation; 2006 Sep; 13(5):380-9. PubMed ID: 16925661
[TBL] [Abstract][Full Text] [Related]
4. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin.
Chawla LS; Georgescu F; Abell B; Seneff MG; Kimmel PL
Am J Kidney Dis; 2005 Mar; 45(3):e51-6. PubMed ID: 15754264
[TBL] [Abstract][Full Text] [Related]
5. [Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain].
Avilés J; Macía M; Morales S; Pérez F; Moreno A; Navarro J; Navazo L; García J
Nefrologia; 2001; 21(4):376-85. PubMed ID: 11816514
[TBL] [Abstract][Full Text] [Related]
6. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure.
Stadlbauer V; Krisper P; Beuers U; Haditsch B; Schneditz D; Jung A; Putz-Bankuti C; Holzer H; Trauner M; Stauber RE
ASAIO J; 2007; 53(2):187-93. PubMed ID: 17413559
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy.
Camus C; Lavoué S; Gacouin A; Compagnon P; Boudjéma K; Jacquelinet C; Thomas R; Le Tulzo Y
Ther Apher Dial; 2009 Dec; 13(6):549-55. PubMed ID: 19954480
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system.
Tan HK; Yang WS; Chow P; Lui HF; Choong HL; Wong KS
Artif Organs; 2007 Mar; 31(3):193-9. PubMed ID: 17343694
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
Mitzner SR; Stange J; Klammt S; Peszynski P; Schmidt R; Nöldge-Schomburg G
J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S75-82. PubMed ID: 11251037
[TBL] [Abstract][Full Text] [Related]
10. Stability of therapeutic albumin solutions used for molecular adsorbent recirculating system-based liver dialysis.
De Bruyn T; Meijers B; Evenepoel P; Laub R; Willems L; Augustijns P; Annaert P
Artif Organs; 2012 Jan; 36(1):29-41. PubMed ID: 21955219
[TBL] [Abstract][Full Text] [Related]
11. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience.
Chiu A; Chan LM; Fan ST
Liver Int; 2006 Aug; 26(6):695-702. PubMed ID: 16842326
[TBL] [Abstract][Full Text] [Related]
12. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
Schmidt LE; Tofteng F; Strauss GI; Larsen FS
Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
[TBL] [Abstract][Full Text] [Related]
13. [The clinical experience with MARS and Prometheus procedures].
Hydzik P; Gawlikowski T; Ciszowski K; Sułlek M
Przegl Lek; 2007; 64(4-5):352-4. PubMed ID: 17724911
[TBL] [Abstract][Full Text] [Related]
14. Continuous modalities of renal replacement therapy. Review of selected aspects.
Grenda R
Rocz Akad Med Bialymst; 2004; 49():178-81. PubMed ID: 15631338
[TBL] [Abstract][Full Text] [Related]
15. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure.
Di Campli C; Santoro MC; Gaspari R; Merra G; Zileri Dal Verme L; Zocco MA; Piscaglia AC; Di Gioacchino G; Novi M; Santoliquido A; Flore R; Tondi P; Proietti R; Gasbarrini G; Pola P; Gasbarrini A
Transplant Proc; 2005; 37(6):2547-50. PubMed ID: 16182739
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of an adult with Amanita phalloides-induced fulminant liver failure with molecular adsorbent recirculating system (MARS).
Lionte C; Sorodoc L; Simionescu V
Rom J Gastroenterol; 2005 Sep; 14(3):267-71. PubMed ID: 16200238
[TBL] [Abstract][Full Text] [Related]
17. MARS dialysis in decompensated alcoholic liver disease: a single-center experience.
Wolff B; Machill K; Schumacher D; Schulzki I
Liver Transpl; 2007 Aug; 13(8):1189-92. PubMed ID: 17663393
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure.
Schaefer B; Schaefer F; Engelmann G; Meyburg J; Heckert KH; Zorn M; Schmitt CP
Nephrol Dial Transplant; 2011 Nov; 26(11):3633-9. PubMed ID: 21421589
[TBL] [Abstract][Full Text] [Related]
19. Emerging indications for albumin dialysis.
Sen S; Williams R; Jalan R
Am J Gastroenterol; 2005 Feb; 100(2):468-75. PubMed ID: 15667509
[TBL] [Abstract][Full Text] [Related]
20. The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure.
Di Campli C; Zocco MA; Gaspari R; Novi M; Candelli M; Santoliquido A; Flore R; Tondi P; Proietti R; Gasbarrini G; Pola P; Gasbarrini A
Transplant Proc; 2005; 37(6):2551-3. PubMed ID: 16182740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
